Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masoud Najafi

Showing results (11-20 of 200) with videos related to

Pageof 20
Sort By:
Journal of Cellular Physiology|December 7, 2018
CD8<sup>+</sup> cytotoxic T lymphocytes in cancer immunotherapy: A reviewBagher Farhood, Masoud Najafi, Keywan Mortezaee
Current Drug Targets|September 9, 2022
Lung Pneumonitis and Fibrosis in Cancer Therapy: A Review on Cellular and Molecular MechanismsChaofeng Xu, Zhongtu Shang, Masoud Najafi
Journal of Cellular Biochemistry|September 28, 2018
Cancer-associated fibroblasts: Secretions, interactions, and therapyBagher Farhood, Masoud Najafi, Keywan Mortezaee
Life Sciences|August 21, 2019
Cancer stem cell (CSC) resistance driversMasoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Life Sciences|November 16, 2019
Stromal reprogramming: A target for tumor therapyMasoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Journal of Cellular Physiology|November 13, 2018
Cancer stem cells (CSCs) in cancer progression and therapyMasoud Najafi, Bagher Farhood, Keywan Mortezaee
Cell Biology International|May 29, 2019
Extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling as a target for cancer therapy: an updated reviewMasoud Najafi, Amirhossein Ahmadi, Keywan Mortezaee
Journal of Cell Communication and Signaling|October 6, 2021
Targeting of the tumor immune microenvironment by metforminZihong Wu, Caidie Zhang, Masoud Najafi
Basic & Clinical Pharmacology & Toxicology|September 2, 2021
Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapyChong Yu, Bo Yang, Masoud Najafi
European Journal of Pharmacology|June 3, 2020
PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer?Milad Ashrafizadeh, Ali Zarrabi, Saeed Samarghandian, et al.
Pageof 20

Showing results (11-20 of 200) with videos related to

Sort By:
Pageof 20
Journal of Cellular Physiology|December 7, 2018
CD8<sup>+</sup> cytotoxic T lymphocytes in cancer immunotherapy: A reviewBagher Farhood, Masoud Najafi, Keywan Mortezaee
Current Drug Targets|September 9, 2022
Lung Pneumonitis and Fibrosis in Cancer Therapy: A Review on Cellular and Molecular MechanismsChaofeng Xu, Zhongtu Shang, Masoud Najafi
Journal of Cellular Biochemistry|September 28, 2018
Cancer-associated fibroblasts: Secretions, interactions, and therapyBagher Farhood, Masoud Najafi, Keywan Mortezaee
Life Sciences|August 21, 2019
Cancer stem cell (CSC) resistance driversMasoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Life Sciences|November 16, 2019
Stromal reprogramming: A target for tumor therapyMasoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Journal of Cellular Physiology|November 13, 2018
Cancer stem cells (CSCs) in cancer progression and therapyMasoud Najafi, Bagher Farhood, Keywan Mortezaee
Cell Biology International|May 29, 2019
Extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling as a target for cancer therapy: an updated reviewMasoud Najafi, Amirhossein Ahmadi, Keywan Mortezaee
Journal of Cell Communication and Signaling|October 6, 2021
Targeting of the tumor immune microenvironment by metforminZihong Wu, Caidie Zhang, Masoud Najafi
Basic & Clinical Pharmacology & Toxicology|September 2, 2021
Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapyChong Yu, Bo Yang, Masoud Najafi
European Journal of Pharmacology|June 3, 2020
PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer?Milad Ashrafizadeh, Ali Zarrabi, Saeed Samarghandian, et al.
Pageof 20